title: Short-term evaluation of periradicular corticosteroid injections in the treatment of lumbar radiculopathy associated with disc disease.
abstract: OBJECTIVE
  The purpose of this study was to evaluate the feasibility and efficacy of periradicular corticosteroid injections performed under fluoroscopic guidance in the treatment of pain originating in the lumbosacral nerve roots.
  
  
  METHODS
  Forty patients presenting with lumbosciatica or femoral neuralgia unresponsive to conventional conservative treatment were admitted to the study. Patients with nerve root pain due to infectious, tumorous or inflammatory diseases were excluded, as were patients who needed immediate surgery. Pain was evaluated using a visual analog scale on the day of the injection and ten (D10) and ninety (D90) days later.
  
  
  RESULTS
  All patients were evaluated as scheduled on D10 and D90. The mean visual analog scale score decreased from 53.3 mm at baseline to 30.1 mm on D10 and to 21.8 mm on D90. Ninety per cent of patients had a visual analog pain score decrease on D10 and 85% on D90. Reported side effects were two cases of mild spontaneously regressive acne and one case of radicular pain exacerbation of less than one day's duration.
  
  
  CONCLUSIONS
  Periradicular injections of corticosteroids done under fluoroscopic guidance as an outpatient procedure was effective and safe in our study and may deserve to be used as part of the conservative management of lumbar nerve root pain before resorting to more invasive methods.
authors.affiliation: Neuroradiology Department, La Timone Teaching Hospital, Marseille, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Viton
authors.forename: T
authors.initials: T
authors.lastname: Rubino
authors.forename: P
authors.initials: P
authors.lastname: Peretti-Viton
authors.forename: G
authors.initials: G
authors.lastname: Bouvenot
authors.forename: A
authors.initials: A
authors.lastname: Delarque
mesh_terms: D000152:Acne Vulgaris / Q000139:chemically induced; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007405:Intervertebral Disc Displacement / Q000150:complications / Q000188:drug therapy*; D017116:Low Back Pain / Q000188:drug therapy; D008159:Lumbar Vertebrae / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008160:Lumbosacral Plexus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced; D010147:Pain Measurement / Q000187:drug effects; D012585:Sciatica / Q000150:complications / Q000188:drug therapy*; D012720:Severity of Illness Index; D013126:Spinal Nerve Roots / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones